Michael O’Brien is the Global Head of Corporate Communications at MedImmune and responsible for all communications functions within the company, in addition to coordination on an enterprise level with AstraZeneca. Under his responsibilities are external communications, internal communications, science and R&D communications, reputation management and branding, in addition to corporate citizenship and community relations.
O’Brien serves on the MedImmune Leadership Team and on the AstraZeneca Global Corporate Affairs Leadership Team.
O’Brien joined MedImmune as Senior Director of Corporate Communications in 2011 and handled management of global external relations teams related to media, reputation management, corporate citizenship, branding and product promotion.
Prior to joining MedImmune, O’Brien worked as the Senior Vice President of the healthcare business unit at IMRE, a full-service, 100-person marketing agency. Clients included: Pfizer Animal Health, Quintiles, Susan G. Komen and SAIC. He also held the position of Vice President in the global healthcare practice at FleishmanHillard, one of the world's largest PR agencies. Clients included: Teva, Bayer, Genentech and Shaping America's Youth.
Previously, O’Brien founded the public relations arm of MGH, Maryland’s largest full-service agency, where he was at partner and worked with Weight Watchers, Pfizer, American Psychological Association and Merck. He was also the Director of Marketing & Public Relations at the Kennedy Krieger Institute (part of Johns Hopkins), and the Communications Director at the Maryland Department of Natural Resources. He began his career as a legal reporter.
O’Brien holds a dual Bachelor’s degree in English-Journalism and Mass Communications from the University of Delaware. His work has earned more than 100 industry awards, including three PRSA Silver Anvils, the highest honor in the industry. Close